Diacetylpiptocarphol is primarily investigated for its potential anti-inflammatory and anticancer properties. It has shown inhibitory effects on the production of pro-inflammatory mediators such as nitric oxide and cytokines, making it a candidate for development in treating inflammatory diseases. In cancer research, it demonstrates cytotoxic activity against certain tumor cell lines by inducing apoptosis and inhibiting cell proliferation. Its ability to modulate key signaling pathways involved in inflammation and cell survival, such as NF-κB, contributes to its therapeutic interest. Due to its natural origin and bioactivity, it is also studied as a lead compound for synthesizing derivatives with enhanced potency and selectivity.